Page last updated: 2024-08-24

halofuginone and Dermatoses

halofuginone has been researched along with Dermatoses in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, W; Cheng, H; Li, Z; Pan, B; Song, G; Tian, J; Xu, K; Zeng, L1
Bona, C; Kodera, T; McGaha, T; Phelps, R; Pines, M; Spiera, H1
Bona, C; McGaha, TL; Phelps, RG; Spiera, H1

Other Studies

3 other study(ies) available for halofuginone and Dermatoses

ArticleYear
Halofugine prevents cutaneous graft versus host disease by suppression of Th17 differentiation.
    Hematology (Amsterdam, Netherlands), 2012, Volume: 17, Issue:5

    Topics: Angiogenesis Inhibitors; Animals; Bone Marrow Transplantation; Cell Differentiation; Chronic Disease; Cytokines; Female; Graft vs Host Disease; Male; Mice; Mice, Inbred BALB C; Piperidines; Quinazolinones; Skin Diseases; Th17 Cells; Time Factors; Transplantation, Homologous

2012
Effect of halofuginone on the development of tight skin (TSK) syndrome.
    Autoimmunity, 2002, Volume: 35, Issue:4

    Topics: Animals; Animals, Newborn; Collagen; Disease Models, Animal; Fibrosis; Humans; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Piperidines; Protein Synthesis Inhibitors; Quinazolines; Quinazolinones; Scleroderma, Systemic; Skin Diseases

2002
Halofuginone, an inhibitor of type-I collagen synthesis and skin sclerosis, blocks transforming-growth-factor-beta-mediated Smad3 activation in fibroblasts.
    The Journal of investigative dermatology, 2002, Volume: 118, Issue:3

    Topics: Animals; Cells, Cultured; Collagen; Collagen Type I; DNA-Binding Proteins; Fibroblasts; Gene Expression; Hyperplasia; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Mice, Mutant Strains; Piperidines; Quinazolines; Quinazolinones; Receptors, Transforming Growth Factor beta; Sclerosis; Signal Transduction; Skin; Skin Diseases; Smad3 Protein; Trans-Activators; Transforming Growth Factor beta

2002